Authors
Latest:
Head Lice Treatment: Perspective for PharmacistsAn estimated 6 to 12 million individuals in the United States develop head lice each year, with most cases occurring in children ages 3 to 11.
Latest:
Specialty Pharmacies and Baby Boomers: Adapting to Meet the Changing Needs of the New Older AmericanThe Baby Boomer generation will stretch the resources of the US health care system, with technology-driven behaviors that force a reevaluation of the delivery of care.
Latest:
TBO-Filgrastim Offers Significant Cost Savings Over Filgrastim in Myeloma TreatmentBone marrow stimulant helps the body make white blood cells after receiving cancer medications.
Latest:
Cost-Effectiveness of Extended-Release Carbidopa-Levodopa for Advanced Parkinson's DiseaseExisting levodopa therapies for Parkinson’s disease often provide inadequate symptom control after prolonged treatment. This study assessed the cost-effectiveness of an extended-release carbidopa-levodopa formulation (IPX066).
Latest:
Frontline Drugs Vancomycin, Fidaxomicin Found to Benefit Transplant Patients With C DifficileAdult patients with Clostrioides difficile infection who received hematopoietic stem cell transplant also benefitted from frontline medications fidaxomicin or oral vancomycin.
Latest:
Examining Treatment Strategies in in Platinum-Sensitive Ovarian CancerPhysicians treating patients with platinum-sensitive ovarian cancer can choose from a range of therapies, including doublet chemotherapy with or without bevacizumab (Avastin) and PARP inhibitors.
Latest:
News & TrendsPharmacists can keep up-to-date on a new requirement in California to provide proof of a Tdap booster for middle and high school students, as well as new studies on the obesity epidemic, asthma care, teen vaccination rates, autism research, and teen prgnancy.
Latest:
Synchronization of Treatment With Erythropoiesis-Stimulating Agents and ChemotherapyIn outpatient oncology clinics, erythropoiesis-stimulating agents and chemotherapy were found to be typically administered during the same visits, as opposed to requiring separate visits.
Latest:
Moving Health Care into the Future: Proposal for Pharmacist-led Refill AuthorizationsPharmacist-led refill authorizations are a practical solution to the nation’s health care crisis, helping to improve quality while reducing costs as well as saving physicians’ time.
Latest:
Provision of Diabetes Sick-Day Plans in the Community PharmacyAs community pharmacists, we are often the most accessible members of the health care team.
Latest:
Exploring the Critical Elements of Hyperkalemia: A Hospital Pharmacist's PerspectiveThis Continuing Education activity is supported by an educational grant from Relypsa, Inc.
Latest:
A Dose of Inspiration: Celebrating the Pharmacist-Patient Relationship During Patient Experience WeekNo matter what role you are in as a pharmacist, no matter where you work or how long you have been practicing, understand that making a difference in the life of a patient matters.
Latest:
Neuropathic Pain: A Glimpse Inside the Unabating AfflictionOriginating from damage within nerve cells themselves, neuropathic pain is often complex, with many treatment challenges.
Latest:
Effect of Dispensing Supply on Pravastatin Refill AdherenceIn uninsured, indigent, and low-income patients with hyperlipidemia, optimum pravastatin refill adherence was observed with a 90-day dispensing supply.
Latest:
Store, Handle, and Administer Vaccines Safely to Prevent ErrorsPharmacists should stay abreast of changes in formulations and recommendations, foster communication with their staff, and plan proactively.
Latest:
Making Sense of Allergic Rhinitis: Key Points in Optimizing Patient Counseling StrategiesPharmacists can learn to apply counseling strategies to help address common patient questions to achieve optimal symptom relief in allergic rhinitis.
Latest:
Occupational Rhinitis: A Hard Day's Work for NosesAbout 5% to 15% of the global workforce is estimated to have an occupational disease.
Latest:
Rx Product News: Profile: A Closer Look at New FDA Actions: SelzentryThis novel agent for HIV patients received accelerated FDA approval.
Latest:
Going the Extra Step to Enhance the ExchangesWhich states can policy makers look to as leaders in creating patient-focused health insurance markets? A series of state-by-state progress reports holds the answer.
Latest:
Natural Medicines: What Is Their Role in Parkinson's Disease Management?Researchers from Jawaharlal Nehru University in New Delhi, India studied an array of natural medicinal products with beneficial effects on mitochondria or redox stabilization.
Latest:
340B Compliance: Tips to Maintaining a Successful ProgramSince its induction in 1992, the 340B Drug Pricing Program has been responsible for helping eligible covered entities stretch scarce federal resources and increase services to patients of the covered entity.
Latest:
Etanercept and Ustekinumab Dosing for Psoriasis and Psoriatic ArthritisFor patients with psoriasis and/or psoriatic arthritis, actual-to-expected dosing ratios and costs were lower for etanercept than for ustekinumab.
Latest:
Vitamin D Deficiency and Patient EducationPharmacists should be aware of the risk factors and signs of vitamin D deficiency to identify patients who would benefit the most from counseling and education.
Latest:
Engage and Consult: a Service Model Designed to Enable SuccessChoosing the right partner in this dynamic environment is an important decision for all stakeholders.
Latest:
Statin-Fenofibrate Combination Therapy in an ACCORD Population: A Retrospective AnalysisRetrospective analysis of a population meeting criteria for the ACCORD lipid trial supported adjunct fenofibrate in patients with reduced low-density lipoprotein cholesterol and elevated triglycerides.
Latest:
Guide to Discussing Influenza Vaccine With PatientsPharmacists, being easily accessible to the community, can offer a unique perspective when discussing the flu vaccine.
Latest:
Cost-Effectiveness of Fingolimod in Treating Patients With Relapsing-Remitting Multiple SclerosisFingolimod, a first-line, once-daily oral disease-modifying therapy for relapsing-remitting multiple sclerosis, has the lowest cost per relapse avoided compared with other first-line agents.
Latest:
Patient Characteristics' Effect on the Conversion Between Basal InsulinsThe characteristics of patients who require increases in their basal insulin dose were compared with those requiring no increase following conversion between basal insulin analogues.
